Provide scientific leadership, direction, and contribution to the strategy employed in early clinical development programs.
Contribute to the study team in the design and development of high quality, timely studies.
Contributes to the medical governance and regulatory reporting at the study level.
Liaises with Clinical Pharmacology, Medical, Commercial, and Asset Leads to ensure study evaluates key aspects of the Asset Product Profile.
Contributes to the scientific oversight of clinical studies, including assurance that data collection and study analysis plans are aligned with the protocols.
Works closely with study physician(s) to help monitor safety and benefit/risk for studies.
Contributes to quality assurance and inspection readiness activities.
Requirements
B.S., Masters, Ph.D., Pharm.D., or MD with 3 plus years of recent clinical drug development experience.
3 plus years contributing to a team, 3rd parties, academic partners, and subcontracted organizations.
Experience with managing multiple programs concurrently.
Prior experience in early clinical development (Phase 1 and 2 studies) or late stage clinical development (Phase 3 studies) preferred.
Prior HIV drug development experience strongly preferred and antiviral, or infectious disease therapeutic area.
Ability to respond with confidence to complex study questions using sound judgment and interpretation of applicable data.
Ability to communicate complex scientific information concisely and clearly.
Ability to influence (internally and externally) without formal authority.
Benefits
ViiV offers US employees receive the same benefits options and plans as GSK employees.